search
Back to results

Marfan Syndrome Moderate Exercise Trial II

Primary Purpose

Marfan Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Intervention Group
Control Group
Sponsored by
Baylor College of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Marfan Syndrome focused on measuring Cardiovascular, Moderate Exercise, Physical Therapy

Eligibility Criteria

10 Years - 25 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Male and female patients diagnosed with Marfan syndrome (defined by Ghent criteria and either a pathogenic variant in FBN1 or ectopia lentis) Age 10-25 years at enrollment Exclusion Criteria: History of aortic surgery History of spinal surgery with implanted materials that may negatively impact MRI safety or imaging quality. Diagnosis of major congenital heart disease (ASD, VSD, bicuspid aortic valve, and mitral valve prolapse will not qualify as exclusion criteria) Condition limiting the ability to perform moderate exercise. Major concurrent diagnosis that may confound the interpretation of the effect of the proposed intervention on the proposed outcome measures. Aortic dilation meeting threshold for prophylactic aortic surgical intervention (>/= 4.5 cm in diameter)

Sites / Locations

  • Texas Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Exercise Intervention Group

Control Group

Arm Description

Group of up to 50 patients will randomly allocated into an experimental group at a 4:1 ratio intervention to controls. The experimental group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) in addition to exercise intervention education, demonstration, and follow up to ensure compliance and safety.

Control group will be randomly allocated at a 4:1 ratio, intervention to controls.. The control group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) and will be instructed to continue with baseline physical activities. They will be asked to return for a reassessment of all baseline procedures (cardiovascular, musculoskeletal, and psychological screening).

Outcomes

Primary Outcome Measures

Maximum VO2
Maximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.

Secondary Outcome Measures

Mean systolic blood pressure
mmHg, range 20-200, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Mean diastolic blood pressure
mmHg, range 20-150, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Mean pulse pressure
mmHg, systolic blood pressure minus diastolic blood pressure, range 30-70 mmHg, goal is normal range for age and sex
Weight
kg, range 50-300kg, lower is better, excluding underweight patients
BMI
kg/m2, lower is better generally, excluding pts with BMI <5% for age
Left ventricular strain by cardiac MRI
Continuous measure derived from post-processing MRI
Right ventricular strain by cardiac MRI
Continuous measure derived from post-processing MRI
Aortic root strain
Continuous measure %, higher is less stiff, Range 0-40
Aortic Root Distensibility
×10-3 mm Hg-1, Continuous measure, range 0.1-10
Aortic Root β-Stiffness index
No units, Range 0.1-90
Maximum aortic root dimension
Measured in cm, range 1-8cm
Aortic root z-score
No units, based on body surface area published references, range -3 to 25
Aortic pulse wave velocity from MRI
meters/second, range 0-30
Pulse wave velocity derived from applanation tonometry
meters/second, range 0-30
Quality of Life Scale (QOLS) (ages 19-21 y)
16 items, each with 7 point Likert, higher is worse
Pediatric Quality of Life Scale (PedsQL) scale scores
reported in 3 domains, each reported on Likert scale, scaled to 0-100 scale, lower is worse
Patient Health Questionnaire-9 (PHQ-9)
Nine-item questionnaire that detects depression and the severity of the depression, scaled from 0-27, higher is worse
Patient Health Questionnaire-4 (PHQ-4) Subset A: Anxiety
Four-question test for anxiety and depression, scaled from 0-12 Subset A (Anxiety): Questions 1 & 2, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.
Patient Health Questionnaire-4 (PHQ-4) Subset B: Depression
Four-question test for anxiety and depression, scaled from 0-12, Subset B (Depression): Questions 3 & 4, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.
Generalized Anxiety Disorder 7-item (GAD-7)
Seven-item questionnaire that detects generalized anxiety disorder and the severity of the anxiety. GAD-7 total score for the seven items ranges from 0 to 21. Using a cut-off of 8 the GAD-7 has a sensitivity of 92% and specificity of 76% for diagnosis generalized anxiety disorder.
Pediatric Symptom Checklist Parent (PSC)
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive.
Pediatric Symptom Checklist Child (PSC-Y)
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems, Internalizing Problems, Externalizing Problems
Pediatric Symptom Checklist Child (PSC-Y): Attention Subscale
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems Subscale: Children with subscores greater than or equal to 7 usually have significant impairments in attention.
Pediatric Symptom Checklist Child (PSC-Y): Internalizing Problems Subscale
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Internalizing Problems Subscale: Children with subscores greater than or equal to 5 usually have significant impairments with anxiety or depression.
Pediatric Symptom Checklist Child (PSC-Y): Externalizing Problems Subscale
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Externalizing Problems Subscale: Children with subscores greater than or equal to 7 usually have significant problems with conduct.
PROMIS Pediatric Self- Reported Psychological Stress
PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Better health is a lower score and worse health scores higher.
PROMIS Parent Proxy Reported Psychological Stress- Parent Proxy
PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Higher score is worse health.

Full Information

First Posted
March 30, 2023
Last Updated
August 9, 2023
Sponsor
Baylor College of Medicine
Collaborators
Southern Star Research Pty Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT05809323
Brief Title
Marfan Syndrome Moderate Exercise Trial II
Official Title
Clinical Trial On The Effects Of Moderate Physical Activity On Health And Well-Being In Adolescents And Young Adults With Marfan Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2023 (Anticipated)
Primary Completion Date
July 1, 2025 (Anticipated)
Study Completion Date
July 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baylor College of Medicine
Collaborators
Southern Star Research Pty Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.
Detailed Description
Marfan syndrome (MFS) is a distinctive connective tissue disorder with clinical phenotypes that affect multiple organ systems including the heart, bones, ligaments, and eyes, and are associated with significant risk of aortic dissection. Given anecdotal reports of aortic dissection, limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities, most commonly isometric exercise and contact sports. Published guidelines also suggest restriction from highly dynamic competitive sports. While clinicians may mean to restrict patients only from competitive sports, often children and families interpret this caution as applying to almost all exercise, resulting in a large number of patients with MFS being sedentary. This lack of exercise and deconditioning likely has detrimental effects in increasing weakness and joint pain and decreasing endurance. Depressive symptoms are also not uncommon in patients with these syndromes, and may be triggered or exacerbated by guidance to acutely cease participation in sports at the time of diagnosis. To date, as far as we are aware, there are no published controlled studies on the effects of dynamic exercise on human subjects. In 2017, Mas-Stachurska et al published a study suggesting that a moderate level of dynamic exercise mitigated progressive degradation of the cardiac structures typically seen in MFS in a rodent sample. This study suggests the possibility that the fears surrounding moderate exercise in humans may be unwarranted. In addition, this study suggests that moderate exercise may actually protect the aorta and myocardium, in addition to the numerous other physical and emotional benefits that have been shown to result from consistent exercise. We have unpublished trial results in a pilot study that also suggest benefit to adolecents and young adults. Given the significant paucity of data currently existing on effects of exercise in humans with MFS, and the recent optimistic findings in rodent models, we plan to conduct a randomized control trial of moderate dynamic exercise in adolescents and young adults with MFS. The objective is to: 1) Randomize 50 patients with Marfan syndrome from ages 10-25 years to current status and care (controls) versus a moderate dynamic exercise intervention, then 2) allow the control group patients to undergo the exercise intervention.The investigators will then compare outcomes between both the intervention and control groups, and between the baseline and post-intervention states. Specific outcome measures will include cardiovascular assessment: maximal oxygen uptake (max VO2), ambulatory blood pressure, segmental and central aortic stiffness, ventricular mass and volume, and endothelial function, physical assessment by the physical therapist, and quality of life/mental health assessment: health-related quality of life, depression and anxiety screening scales. The hypothesis is that the intervention of a moderate exercise program introduced by a licensed physical therapist will result in improvement in cardiovascular status, muscular health, and mental health without detrimental effects on the aortic wall.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Marfan Syndrome
Keywords
Cardiovascular, Moderate Exercise, Physical Therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The interventional study will be conducted as a parallel study model, with 2 groups in total: Exercise Intervention Group (interventional group) and Current Care Group (control group). Baseline and follow up testing will occur in both groups at identical time intervals.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise Intervention Group
Arm Type
Experimental
Arm Description
Group of up to 50 patients will randomly allocated into an experimental group at a 4:1 ratio intervention to controls. The experimental group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) in addition to exercise intervention education, demonstration, and follow up to ensure compliance and safety.
Arm Title
Control Group
Arm Type
Other
Arm Description
Control group will be randomly allocated at a 4:1 ratio, intervention to controls.. The control group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) and will be instructed to continue with baseline physical activities. They will be asked to return for a reassessment of all baseline procedures (cardiovascular, musculoskeletal, and psychological screening).
Intervention Type
Other
Intervention Name(s)
Exercise Intervention Group
Intervention Description
Patients will be educated on methods of self-evaluating exertion and cardiovascular effort by assessing respiratory rate and perceived exertion. Next, patients will be given options for cardiovascular activities and complete at a moderate level of activity for a minimum of 150 minutes per week. Patients will perform a combination of exercises under the supervision of a physical therapist until a mod intensity level is reached and sustained. Patients will be taught to use the activity tracker to record their heart rate, activity, and PES. Patients will have a phone call every week to assess status, answer questions, and provide guidance on progressing intensity or duration of exercise. At the end of 12 weeks all patients will return for re-assessment.
Intervention Type
Other
Intervention Name(s)
Control Group
Other Intervention Name(s)
No Intervention
Intervention Description
Patients in the control group will be instructed to continue with baseline physical activities over the duration of the study and be given instructions on the use of the activity tracker. At the end of 12 weeks all patients will return for re-assessment.
Primary Outcome Measure Information:
Title
Maximum VO2
Description
Maximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.
Time Frame
4 Months
Secondary Outcome Measure Information:
Title
Mean systolic blood pressure
Description
mmHg, range 20-200, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Time Frame
4 Months
Title
Mean diastolic blood pressure
Description
mmHg, range 20-150, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Time Frame
4 Months
Title
Mean pulse pressure
Description
mmHg, systolic blood pressure minus diastolic blood pressure, range 30-70 mmHg, goal is normal range for age and sex
Time Frame
4 Months
Title
Weight
Description
kg, range 50-300kg, lower is better, excluding underweight patients
Time Frame
4 Months
Title
BMI
Description
kg/m2, lower is better generally, excluding pts with BMI <5% for age
Time Frame
4 Months
Title
Left ventricular strain by cardiac MRI
Description
Continuous measure derived from post-processing MRI
Time Frame
4 Months
Title
Right ventricular strain by cardiac MRI
Description
Continuous measure derived from post-processing MRI
Time Frame
4 Months
Title
Aortic root strain
Description
Continuous measure %, higher is less stiff, Range 0-40
Time Frame
4 Months
Title
Aortic Root Distensibility
Description
×10-3 mm Hg-1, Continuous measure, range 0.1-10
Time Frame
4 Months
Title
Aortic Root β-Stiffness index
Description
No units, Range 0.1-90
Time Frame
4 Months
Title
Maximum aortic root dimension
Description
Measured in cm, range 1-8cm
Time Frame
4 Months
Title
Aortic root z-score
Description
No units, based on body surface area published references, range -3 to 25
Time Frame
4 Months
Title
Aortic pulse wave velocity from MRI
Description
meters/second, range 0-30
Time Frame
4 Months
Title
Pulse wave velocity derived from applanation tonometry
Description
meters/second, range 0-30
Time Frame
4 Months
Title
Quality of Life Scale (QOLS) (ages 19-21 y)
Description
16 items, each with 7 point Likert, higher is worse
Time Frame
4 Months
Title
Pediatric Quality of Life Scale (PedsQL) scale scores
Description
reported in 3 domains, each reported on Likert scale, scaled to 0-100 scale, lower is worse
Time Frame
4 Months
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
Nine-item questionnaire that detects depression and the severity of the depression, scaled from 0-27, higher is worse
Time Frame
4 Months
Title
Patient Health Questionnaire-4 (PHQ-4) Subset A: Anxiety
Description
Four-question test for anxiety and depression, scaled from 0-12 Subset A (Anxiety): Questions 1 & 2, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.
Time Frame
4 Months
Title
Patient Health Questionnaire-4 (PHQ-4) Subset B: Depression
Description
Four-question test for anxiety and depression, scaled from 0-12, Subset B (Depression): Questions 3 & 4, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.
Time Frame
4 Months
Title
Generalized Anxiety Disorder 7-item (GAD-7)
Description
Seven-item questionnaire that detects generalized anxiety disorder and the severity of the anxiety. GAD-7 total score for the seven items ranges from 0 to 21. Using a cut-off of 8 the GAD-7 has a sensitivity of 92% and specificity of 76% for diagnosis generalized anxiety disorder.
Time Frame
Every 2 Weeks for 4 Months
Title
Pediatric Symptom Checklist Parent (PSC)
Description
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive.
Time Frame
4 Months
Title
Pediatric Symptom Checklist Child (PSC-Y)
Description
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems, Internalizing Problems, Externalizing Problems
Time Frame
4 Months
Title
Pediatric Symptom Checklist Child (PSC-Y): Attention Subscale
Description
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems Subscale: Children with subscores greater than or equal to 7 usually have significant impairments in attention.
Time Frame
4 Months
Title
Pediatric Symptom Checklist Child (PSC-Y): Internalizing Problems Subscale
Description
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Internalizing Problems Subscale: Children with subscores greater than or equal to 5 usually have significant impairments with anxiety or depression.
Time Frame
4 Months
Title
Pediatric Symptom Checklist Child (PSC-Y): Externalizing Problems Subscale
Description
The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English & Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Externalizing Problems Subscale: Children with subscores greater than or equal to 7 usually have significant problems with conduct.
Time Frame
4 Months
Title
PROMIS Pediatric Self- Reported Psychological Stress
Description
PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Better health is a lower score and worse health scores higher.
Time Frame
4 Months
Title
PROMIS Parent Proxy Reported Psychological Stress- Parent Proxy
Description
PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Higher score is worse health.
Time Frame
4 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female patients diagnosed with Marfan syndrome (defined by Ghent criteria and either a pathogenic variant in FBN1 or ectopia lentis) Age 10-25 years at enrollment Exclusion Criteria: History of aortic surgery History of spinal surgery with implanted materials that may negatively impact MRI safety or imaging quality. Diagnosis of major congenital heart disease (ASD, VSD, bicuspid aortic valve, and mitral valve prolapse will not qualify as exclusion criteria) Condition limiting the ability to perform moderate exercise. Major concurrent diagnosis that may confound the interpretation of the effect of the proposed intervention on the proposed outcome measures. Aortic dilation meeting threshold for prophylactic aortic surgical intervention (>/= 4.5 cm in diameter)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shaine A Morris, MD, MPH
Phone
832-826-5692
Email
shainem@bcm.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Bogardus, PT, MPT, PhD
Phone
713-794-2070
Email
jennifer.bogardus@utah.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shaine A Morris, MD, MPH
Organizational Affiliation
Baylor College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Texas Children's Hospital
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shaine A Morris, MD MPH
Phone
832-826-5682
Email
shainem@bcm.edu
First Name & Middle Initial & Last Name & Degree
Jennifer Bogardus, PT, MPT, PhD
Phone
713-794-2070
Email
jbogardus@twu.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Marfan Syndrome Moderate Exercise Trial II

We'll reach out to this number within 24 hrs